scholarly article | Q13442814 |
P356 | DOI | 10.1038/JHG.2012.92 |
P698 | PubMed publication ID | 22951595 |
P50 | author | Soo Heon Kwak | Q37639251 |
Jihyun Song | Q59160026 | ||
P2093 | author name string | Eun-Ju Lee | |
Jong-Young Lee | |||
Min Jin Go | |||
Hye Jin Lee | |||
Hak C Jang | |||
Myeong-Chan Cho | |||
Kyung-Hee Park | |||
Yeon-Ah Sung | |||
Han Byul Jang | |||
Hye-Ja Lee | |||
Joo-Yeon Hwang | |||
Hyung-Lae Kim | |||
Kyung Soo Park | |||
P2860 | cites work | Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 |
Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 | Q28943454 | ||
A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0 | Q33522045 | ||
Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). | Q33525709 | ||
FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome | Q33809190 | ||
A stratified transcriptomics analysis of polygenic fat and lean mouse adipose tissues identifies novel candidate obesity genes | Q34018876 | ||
Association of CAPN10 SNPs and haplotypes with polycystic ovary syndrome among South Indian Women | Q34182337 | ||
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women | Q34489447 | ||
Genomic control, a new approach to genetic-based association studies | Q34539204 | ||
Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome | Q34708805 | ||
Association of TRB3 Q84R polymorphism with polycystic ovary syndrome in Chinese women | Q34980497 | ||
Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome | Q35072186 | ||
The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma. | Q35676497 | ||
Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study | Q35767806 | ||
The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome | Q35841226 | ||
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts | Q36507128 | ||
Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome | Q36812563 | ||
Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes | Q36920069 | ||
Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). | Q36946868 | ||
Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects | Q36971939 | ||
First evidence of genetic association between AKT2 and polycystic ovary syndrome | Q36975665 | ||
Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. | Q37257592 | ||
An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome | Q37689166 | ||
The link between polycystic ovary syndrome and both Type 1 and Type 2 diabetes mellitus: what do we know today? | Q37989176 | ||
The role of obesity in the development of polycystic ovary syndrome | Q37989225 | ||
Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes | Q38464227 | ||
Association of insulin receptor genetic variants with polycystic ovary syndrome in a population of women from Central Europe | Q39870900 | ||
Fas apoptosis inhibitory molecule regulates T cell receptor-mediated apoptosis of thymocytes by modulating Akt activation and Nur77 expression. | Q39982673 | ||
Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome | Q41664900 | ||
Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? | Q43139153 | ||
Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome | Q43242263 | ||
FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome | Q46524994 | ||
Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome | Q46597438 | ||
Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis | Q47588580 | ||
A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits | Q47936547 | ||
Metabolic Heterogeneity in Polycystic Ovary Syndrome Is Determined by Obesity: Plasma Metabolomic Approach Using GC-MS | Q59517933 | ||
Obesity and polycystic ovary syndrome | Q63916535 | ||
Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women | Q82084007 | ||
Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. | Q82493109 | ||
Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome | Q83879344 | ||
Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis | Q84552914 | ||
P4510 | describes a project that uses | genome-wide association study | Q1098876 |
P433 | issue | 10 | |
P921 | main subject | obesity | Q12174 |
polycystic ovary | Q5547896 | ||
polycystic ovary syndrome | Q500816 | ||
genome-wide association study | Q1098876 | ||
P304 | page(s) | 660-664 | |
P577 | publication date | 2012-09-06 | |
P1433 | published in | Journal of Human Genetics | Q6295302 |
P1476 | title | Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition. | |
P478 | volume | 57 |
Q36742634 | A subpathway-based method of drug reposition for polycystic ovary syndrome |
Q59049526 | Genetic Markers of Polycystic Ovary Syndrome: Emphasis on Insulin Resistance |
Q36339954 | Genetic Predisposition to Polycystic Ovary Syndrome, Postpartum Weight Reduction, and Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes |
Q50594798 | Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome. |
Q38771084 | Is foetal hyperexposure to androgens a cause of PCOS? |
Q36378517 | Paternal history of diabetes mellitus and hypertension affects the prevalence and phenotype of PCOS. |
Q36716040 | Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity |
Q28390200 | Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome |
Q39441112 | The role of epistasis in the etiology of Polycystic Ovary Syndrome among Indian women: SNP-SNP and SNP-environment interactions |